Abstracts
(7830)
POSTER PRESENTATIONS
(3124)
Basic and Translational Investigations
(1759)
CLINICAL INVESTIGATIONS
(1552)
Abstracts from the 2024 Society For Neuro-Oncology’s 29th Annual Meeting and Education Day
(1304)
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
(898)
26TH ANNUAL MEETING & EDUCATION DAY OF THE SOCIETY FOR NEURO-ONCOLOGY
(896)
Oral Presentations
(775)
Supplement Abstracts
(690)
Tumor Microenvironment
(336)
Editorials
(335)
Original Articles
(333)
Editorial
(325)
Pediatric Neuro-Oncology
(294)
Preclinical Experimental Therapeutics
(280)
Reviews
(274)
Review
(264)
Tumor Models
(252)
Immunology
(247)
Neuro-Imaging
(239)
Clinical Trials: Non-Immunologic
(228)
Final category: Preclinical Experimental Therapeutics
(227)
LOW GRADE GLIOMA
(226)
Neuroimaging
(219)
CELL SIGNALING AND SIGNALING PATHWAYS
(212)
Poster Presentations
(212)
Final category: Tumor Microenvironment
(204)
Neuro-imaging
(198)
Letters to the Editor
(195)
P14 CLINICAL NEURO-ONCOLOGY
(193)
Biomarkers
(192)
MEDULLOBLASTOMA
(186)
Innovations in Patient Care
(181)
Molecular Pathology and Classification - Adult and Pediatric
(179)
Abstracts from the 3rd Biennial Conference on Pediatric Neuro-Oncology Basic and Translational Research
(175)
P01 Glioma - Clinical Aspects
(169)
EPIDEMIOLOGY
(165)
Society News
(163)
Genetics and Epigenetics
(161)
Outcome Measures and Neuro-Cognitive Outcomes
(161)
P11 Clinical neuro-oncology
(161)
Final category: Immunobiology
(160)
supplement articles
(160)
FINAL CATEGORY: NEUROIMAGING
(157)
Experimental Therapeutics
(155)
HIGH GRADE GLIOMA
(155)
Molecular Pathology & Classification
(155)
Final category: Surgical Therapies
(153)
QUALITY OF LIFE
(147)
EPENDYMOMA
(146)
Adult Clinical Trials - non-Immunologic
(145)
CNS Metastasis
(139)
Clinical Radiotherapy
(138)
(Epi)Genetics and Computational Omics
(137)
Diffuse Midline Glioma/DIPG
(137)
STEM CELLS
(133)
Final Category: Biomarkers
(128)
posters
(128)
Surgical Therapies
(127)
HIGH GRADE GLIOMAS AND DIPG
(124)
Clinical Trials: Immunologic
(110)
Adult Clinical Trials – Immunologic
(109)
Final category: Medulloblastoma
(109)
Rare Tumors
(109)
Drug Discovery, Drug Resistance
(106)
Final category: Tumor Metabolism
(105)
Final category: Cancer Neuroscience
(104)
Final category: Molecular Pathology & Classification
(103)
POSTER
(103)
Original Research Articles
(101)
Quality of Life and Palliative Care
(101)
Immunobiology
(100)
ADULT TUMORS - EXPERIMENTAL/NOVEL THERAPEUTICS - PRECLINICAL STUDIES (NON-IMMUNOLOGICAL)
(99)
GERM CELL TUMORS
(98)
Letter to the Editor
(97)
Cell Biology and Metabolism
(96)
CELL BIOLOGY
(94)
Glioblastoma and anaplastic gliomas
(94)
Craniopharyngioma and Rare Tumors
(93)
P05 Other Tumor - Clinical Aspects
(93)
Final category: Diffuse Midline Glioma, Diffuse Intrinsic Pontine Glioma
(92)
P04 Glioma - Preclinical Aspects
(92)
Health Outcome Measures
(91)
Surgical Therapy
(90)
FINAL CATEGORY: CLINICAL RADIOTHERAPY
(89)
Medulloblastoma
(89)
Posters
(89)
Neurological Complications of Cancer
(88)
Final category: Drug Discovery, Drug Resistance
(87)
Pediatric Tumors
(87)
DRUG DISCOVERY
(86)
Final category: Neuro-imaging
(86)
NEURO-IMAGING (CLINICAL AND/OR LABORATORY RESEARCH)
(84)
Final category: Clinical trials: Non-immunologic
(82)
Final category: Tumor models
(82)
PRECLINICAL EXPERIMENTAL THERAPEUTICS
(82)
Neuropsychology/Quality of Life
(81)
DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
(80)
Highlights from the Literature
(80)
Monday, July 21, 2014
(80)
News and Announcements
(80)
TRANSLATIONAL THERAPEUTICS
(80)
Articles
(79)
Cancer Neuroscience
(79)
Experimental Therapeutics – non-immunological
(79)
TUMOR MICROENVIRONMENT/ANGIOGENESIS/METABOLISM/INVASION
(78)
BIOMARKERS
(77)
Final Category: Clinical Trials: Non-Immunologic
(76)
Final category: Epidemiology
(76)
NEUROIMAGING (PRECLINICAL AND CLINICAL)
(76)
P08 Glioblastom and Anaplastic gliomas
(76)
DIPG/DIFFUSE MIDLINE GLIOMA
(75)
Final category: Biomarkers
(75)
NEURO-IMAGING
(73)
Radiation Therapy
(71)
Epidemiology
(70)
Final category: Cancer neuroscience
(70)
EXPERIMENTAL AND BIOLOGICAL THERAPEUTICS (CLINICAL AND/OR LABORATORY)
(69)
Tuesday, July 22, 2014
(69)
Angiogenesis and Invasion
(68)
Final category: Molecular pathology & classification
(68)
Final category: Quality of Life
(68)
P08 Gliomas: experimental
(68)
Final category: Outcome Measures and Neuro-Cognitive Outcomes
(67)
Final category: (Epi)Genetics and Computational Omics
(66)
Adult Clinical Trials – Non-Immunologic
(65)
BNOS 2021 Abstracts
(65)
BNOS 2024 Abstracts: Poster Presentations
(65)
Final category: Innovations in Patient Care
(65)
P11 PRECLINICAL NEURO-ONCOLOGY
(65)
Radiation
(65)
Society for Neuro-Oncology Virtual Conference on Brain Metastases, August 14, 2020, held in association with the AANS/CNS Section on Tumors
(64)
oral presentations
(64)
MEDULLOBLASTOMA – BASIC/TRANSLATIONAL RESEARCH
(62)
P12 Adult glioma
(62)
Tumor Microenvironment/Angiogenesis/Metabolism/Invasion
(62)
High Grade Glioma
(61)
Tumor Metabolism
(61)
ADULT CLINICAL TRIALS
(60)
Final category: (EPI)Genetics and computational omics
(60)
Low Grade Glioma
(60)
NEUROSURGERY
(60)
P09 Glioblastoma: clinical
(60)
P10 Preclinical neuro-oncology
(60)
CLINICAL TRIALS: NON-IMMUNOLOGIC
(59)
E-Poster Presentations
(59)
Final category: Low Grade Glioma
(59)
IMMUNOLOGY/IMMUNOTHERAPY
(58)
Preclinical Models/Experimental Therapy/Drug Discovery
(58)
QUALITY OF LIFE/SURVIVAL/REHABILITATION
(58)
QUALITY OF SURVIVAL AND NEURO-REHABILITATION
(58)
Corrigenda
(57)
Corrigendum
(57)
Final Category: Diffuse Intrinsic Pontine Glioma/Diffuse Midline Gliomas - DPIG
(57)
IMMUNOTHERAPY
(56)
Medulloblastoma (Research)
(56)
BNOS 2022 Abstracts: Oral Presentations
(55)
Brief Communication
(55)
Final category: High Grade Glioma
(55)
Meningioma
(55)
P18 Adult glioma
(54)
Final category: Neuropsychology, Quality of Life, Survivorship
(53)
IMMUNOLOGY
(52)
PCNSL (ML)
(52)
BNOS 2022 Abstracts: Poster Presentations
(51)
FINAL CATEGORY: TRIALS IN PROGRESS
(51)
Molecular Tumor Board Case Report
(51)
Others (not fitting any other category)
(51)
BNOS 2023 ABSTRACTS: ORAL PRESENTATIONS
(50)
Cancer Stem Cell
(50)
DRUG DISCOVERY, DRUG RESISTANCE
(50)
Final category: Clinical radiotherapy
(50)
Final category: Drug discovery, drug resistance
(49)
Final category: Outcome measures and neuro-cognitive outcomes
(49)
MEDULLOBLASTOMA/ PRIMITIVE NEUROECTODERMAL TUMORS (PNETS)
(49)
BNOS 2019 Abstracts: Oral Presentations
(48)
DRUG RESISTANCE
(48)
P17 Clinical neuro-oncology
(48)
BNOS 2023 ABSTRACTS: POSTER PRESENTATIONS
(47)
MOLECULAR PATHOLOGY & CLASSIFICATION
(47)
Neurological Complications of Cancer and Cancer Therapy
(47)
P01 Tumour cell biology, heterogeneity and plasticity
(47)
ABSTRACTS FROM THE 3RD SNO-SCIDOT JOINT CONFERENCE ON THERAPEUTIC DELIVERY TO THE CNS
(46)
MEDULLOBLASTOMA – CLINICAL
(46)
OUTCOME MEASURES AND NEURO-COGNITIVE OUTCOMES
(46)
Pediatric Tumors - non-immunological
(46)
RADIATION ONCOLOGY
(46)
ABSTRACTS FROM THE SOCIETY FOR NEURO-ONCOLOGY (SNO) AND THE SOCIETY FOR CNS INTERSTITIAL DELIVERY OF THERAPEUTICS (SCIDOT) JOINT CONFERENCE ON THERAPEUTIC DELIVERY TO THE CNS
(45)
BNOS 2018 Abstracts: Oral Presentations
(45)
Medulloblastoma (Clinical)
(45)
Ependymoma
(44)
Erratum
(44)
Final Category: Medulloblastomas - MDB
(44)
IMMUNOLOGY - BIOLOGY, PRECLINICAL STUDIES AND MECHANISMS OF RESISTANCE (ADULT + PEDIATRIC TUMORS)
(44)
Neuro-Cognitive Outcomes
(44)
PEDIATRIC BRAIN TUMOR MODELS
(44)
Radiation Oncology
(44)
TUMOR MODELS
(44)
Case Study
(43)
Supplement Article
(43)
High Grade Gliomas
(42)
Imaging
(42)
Celll Signaling and Signaling Pathways
(41)
GENOMICS AND MOLECULAR PATHOLOGY (CLINICAL AND/OR LABORATORY RESEARCH)
(41)
INNOVATIONS IN PATIENT CARE
(41)
Pediatric Neuro-Oncology in Asia and other Low/Middle Income Countries
(41)
BRAIN METASTASES (PRECLINICAL AND CLINICAL)
(40)
Computational Omics
(40)
EPIDEMIOLOGY, CLINICAL
(40)
Invited Lectures
(40)
P11 Brain metastasis and leptomeningeal disease
(40)
P20 Rare CNS tumors
(40)
Quality Improvement
(40)
Radiation therapy
(40)
orals
(40)
BNOS 2019 Abstracts: Poster Presentations
(39)
Book Reviews
(39)
Final Category: Clinical Trials: Immunologic
(39)
Meta-analysis/Systematic Review
(39)
ATYPICAL TERATOID RHABDOID TUMORS (ATRT)
(38)
CRANIOPHARYNGIOMA/RARE TUMORS
(38)
Final category: Health Disparities and Equity
(38)
NOVEL THERAPEUTICS (CLINICAL AND/OR LABORATORY RESEARCH)
(38)
ORAL POSTERS
(38)
Wednesday, July 23, 2014
(38)
Author Index
(37)
BRAIN METASTASES (CLINICAL AND/OR LABORATORY RESEARCH)
(37)
ETMR and other Embryonal Tumors
(37)
FINAL CATEGORY: SCREENING/DIAGNOSTICS/PROGNOSTICS
(37)
Final category: Cell Signaling and Cell Cycle Regulation
(37)
GENOMICS
(37)
Neurosurgery
(37)
P01 Molecular and cell biology
(37)
P02 Tumor heterogeneity, plasticity and impact on therapeutic response
(37)
P17 Recurrent glioblastoma
(37)
RADIOLOGY
(37)
Tumor Biology
(37)
ADULT TUMORS - CLINICAL TRIALS (NON-IMMUNOLOGICAL) PHASES II, III, IV
(36)
Epidemiology & Biostatistics
(36)
Final category: Innovations in patient care
(36)
Final category: Neurological Complications of Cancer
(36)
PEDIATRIC CLINICAL TRIALS
(36)
QUALITY OF LIFE AND PALLIATIVE CARE
(36)
RADIATION THERAPY (CLINICAL AND/OR LABORATORY RESEARCH)
(36)
Basic and Translational Investigation
(35)
CNS PNET AND RARE TUMOURS
(35)
Final category: Clinical trials: Immunologic
(35)
CLINICAL RADIOTHERAPY
(34)
Drug Delivery
(34)
Final Category: Multimodality Approaches
(34)
Final category: Cell signaling and signaling pathways
(34)
Final category: Clinical Research Methods
(34)
Final category: Imaging
(34)
IMMUNOTHERAPY/VACCINE THERAPY (CLINICAL AND/OR LABORATORY RESEARCH)
(34)
Metabolic Drug Targets, Resistance
(34)
(EPI)GENETICS AND COMPUTATIONAL OMICS
(33)
CLINICAL TRIALS: IMMUNOLOGIC
(33)
Cell Signaling and Signaling Pathways
(33)
EPIDEMIOLOGY (MOLECULAR AND CLINICAL)
(33)
Leptomeningeal Disease
(33)
Neuroimaging of brain tumours
(33)
New developments in radiotherapy
(33)
Tumor Biology (not fitting a specific disease category)
(33)
Abstracts from the 3rd CNS Anticancer Drug Discovery and Development Conference
(32)
Embryonal Tumors
(32)
Final category: Drug Delivery
(32)
Final category: Embryonal Tumor with Multilayered Rosettes (ETMR), Other Embryonal Tumors, Rare tumors
(32)
Health Disparities and Equity
(32)
P01 Cognition in brain tumors
(32)
P02 Microenvironment
(32)
P27 Clinical neuro-oncology
(32)
Atypical Teratoid/Rhabdoid Tumors
(31)
BNOS 2018 Abstracts: Poster Presentations
(31)
MOLECULAR PATHOLOGY AND CLASSIFICATION (ADULT AND PEDIATRIC)
(31)
P15 Development and validation of innovative imaging strategies (PET, metabolic MRI)
(31)
Radiobiology
(31)
Cancer Stem Cells
(30)
FINAL CATEGORY: BASIC SCIENCE OF BRAIN METASTASES
(30)
Final category: Ependymoma
(30)
Final category: Neurofibromatosis and other Cancer Predisposition Syndromes
(30)
Other
(30)
P12 IMMUNOTHERAPY
(30)
P16 Neurosurgery
(30)
PEDIATRIC TUMORS - BIOLOGY AND PRECLINICAL STUDIES (NON-IMMUNOLOGICAL)
(30)
SNO MAXIMAL SAFE BRAIN TUMOR RESECTION: INTRAOPERATIVE VISUALIZATION AND THE CONNECTOME CONFERENCE
(30)
ADULT TUMORS - EXPERIMENTAL/NOVEL THERAPEUTICS - CLINICAL TRIALS (NON-IMMUNOLOGICAL) PHASES O, I, COMBINED I-II
(29)
ANGIOGENESIS AND INVASION (CLINICAL AND/OR LABORATORY RESEARCH)
(29)
CLINICAL OTHERS (COT)
(29)
Final Category: Other
(29)
Final Category: Radiation Therapy Advances
(29)
Final category: Neurological complications of cancer
(29)
Final category: Others (not fitting any other category)
(29)
Final category: Radiobiology
(29)
MENINGIOMA/VESTIBULAR SCHWANNOMA/SKULL BASE TUMORS/OTHER (CLINICAL AND/OR LABORATORY RESEARCH)
(29)
NEUROIMAGING (NI)
(29)
P14 Rare CNS tumors
(29)
P17 Brain metastasis and leptomeningeal disease
(29)
Pathology and Molecular Diagnosis
(29)
Stem cells
(29)
TUMOR BIOLOGY/PATHOLOGY (NOT FITTING A SPECIFIC DISEASE CATEGORY)
(29)
Brain and leptomeningeal metastases
(28)
Final Category: High Grade Glioma/Gliomatosis Cerebri - HGG
(28)
Final category: Germ Cell Tumors
(28)
Neuroimaging (NI)
(28)
P06 Immunotherapy
(28)
P10 Pediatric brain tumors
(28)
Radiation Biology and DNA Repair
(28)
SURGICAL THERAPY (PRECLINICAL AND CLINICAL)
(28)
Covid-19 and Neuro-Oncology
(27)
DNA Repair/Modulation
(27)
Final Category: Meningioma
(27)
Final category: Pediatric Neuro-Oncology in Low/Middle Income Countries
(27)
P03 Imaging
(27)
P03 Radiation technologies/Radiobiology/Radiotoxicity/Radiosensitizers
(27)
P04 Neuroimaging
(27)
P05 Advanced diagnostics and biomarkers
(27)
P10 Other gliomas: clinical
(27)
Surgery
(27)
Atypical Teratoid Rhabdoid Tumor
(26)
Clinical Others (COT)
(26)
Clinical Studies (CS)
(26)
EPIDEMIOLOGY & BIOSTATISTICS
(26)
Final category: Cancer Stem Cell
(26)
Germ Cell Tumors
(26)
Molecular markers
(26)
P10 Artificial intelligence/Machine learning/Computational neuro-oncology
(26)
ADULT CLINICAL TRIALS/THERAPEUTIC STUDIES (ACT)
(25)
Basic Science
(25)
CANCER STEM CELLS
(25)
CELL BIOLOGY (CELL CYCLE REGULATION, DNA REPAIR/MODULATION)
(25)
Cell Biology (Cell Cycle Regulation, DNA Repair/Modulation)
(25)
Early Phase Clinical Trials
(25)
Final Category: Paediatric Oncology
(25)
Final category: Quality Improvement
(25)
Multimodality
(25)
P02 Tumor microenvironment
(25)
P03 Neuropathology
(25)
P12 Meningiomas
(25)
P18 Preclinical neuro-oncology
(25)
Randomized Trials in Development
(25)
Rare Tumors/Other
(25)
Translational/Early Phase Clinical Trials
(25)
Basic science
(24)
CRANIOPHARYNGIOMA
(24)
Drug Delivery/Pharmacokinetics
(24)
FINAL CATEGORY: PEDIATRIC NEURO ONCOLOGY
(24)
Final Category: Basic Biology/Stem Cells/Models - BIOL
(24)
Final Category: Systemic Therapeutics
(24)
GENETICS/EPIGENETICS
(24)
Invited Reviews
(24)
P14 Advanced techniques in Neuro-Oncology (diagnosis and/ or treatment)
(24)
RADIATION THERAPY AND RADIOBIOLOGY
(24)
BNOS 2024 Abstracts: Oral Presentations
(23)
Breaking News Editorial
(23)
CLINICAL INVESTIGATION
(23)
Cell biology and signalling
(23)
FINAL CATEGORY: SYSTEMIC THERAPEUTICS
(23)
Final Category: Immunology/Immunotherapy - IMMU
(23)
Final Category: Low Grade Gliomas - LGG
(23)
Final Category: Omics of Tumor Microenvironment
(23)
Final category: Nursing, Social Work, Patient Support
(23)
HEALTH CARE PROCESSES, OUTCOMES, POLICY (GUIDELINES, CARE PATHWAYS, COST ANALYSIS, PATIENT SATISFACTION, ETHNIC/GENDER ISSUES, IMPACT OF HEATH CARE POLICIES ON NEURO-ONCOLOGY)
(23)
Immunotherapy
(23)
MOLECULAR PATHOLOGY/CLASSIFICATION (MPC)
(23)
P08 Immunotherapy
(23)
P14 Brain and leptomeningeal metastases: clinical
(23)
PRECLINICAL TUMOR/ANIMAL MODELS
(23)
Pediatric Neuro-Oncology in Low/Middle Income Countries
(23)
RARE TUMORS IN ADULTS (LYMPHOMAS, SPORADIC SCHWANNOMAS, MPNST, SPINAL CORD, EPENDYMOMA, BASE OF SKULL, OTHER)
(23)
ATYPICAL TERATOID/RHABDOID TUMOR (AT/RT)
(22)
Case Studies
(22)
EARLY PHASE TRIALS AND DRUG DELIVERY
(22)
Final category: Angiogenesis and Invasion
(22)
Final category: Immune-, Cell-, Gene-, and Viral-Based Therapies
(22)
Final category: Molecular Pathology and Classification: Pediatrics
(22)
GERM CELL TUMOURS
(22)
Genetics/Epigentics
(22)
IMMUNOLOGY - ADULT AND PEDIATRIC CLINICAL TRIALS (PHASES O, I, II, III, IV)
(22)
Metabolic Biomarkers and Imaging
(22)
P07 Neuroimaging of brain tumours
(22)
P07 Neurosurgery, drug delivery and advanced techniques
(22)
P15 Palliative and supportive care/QoL
(22)
PRE-CLINICAL MODELS
(22)
COMPLICATIONS OF THERAPY AND NEUROTOXICITY
(21)
Final Category: Basic Science
(21)
Final category: Quality improvement
(21)
MECHANISMS OF TREATMENT RESISTANCE (MEDICAL/RADIATION/SURGICAL) (PRECLINICAL AND CLINICAL)
(21)
Molecular Pathology/Classification (MPC)
(21)
NURSING
(21)
P18 Meningioma
(21)
Social Work/Patient Support/Palliative Care
(21)
Clinical Neuro-Oncology
(20)
FINAL CATEGORY: LOCAL AND MULTIMODALITY APPROACHES
(20)
Final Category: Neuroimaging/Radiologic Advances
(20)
Final Category: Translational Science
(20)
Final category: Atypical Teratoid Rhabdoid Tumor
(20)
Final category: Cancer stem cell
(20)
MENINGIOMA (PRECLINICAL AND CLINICAL)
(20)
NEURO-COGNITIVE FUNCTION/QOL/PATIENT CARE/PALLIATIVE CARE (NQPC)
(20)
NURSING, CLINICAL AND RESEARCH
(20)
P06 Biomarkers
(20)
P09 Radiation
(20)
P13 Meningioma
(20)
Pediatric Clinical Trials and Outcomes
(20)
TUMOR MICROENVIRONMENT
(20)
TUMOUR BIOLOGY
(20)
ATYPICAL TERATOID RHABDOID TUMOR (ATRT)
(19)
Book Review
(19)
DRUG DELIVERY (PRECLINICAL AND CLINICAL)
(19)
EPIGENOMICS
(19)
Final Category: ATRT/Embryonal/ETMR - ATRT
(19)
Final category: Health disparities and equity
(19)
MICROENVIRONMENT, TUMOR
(19)
NEUROLOGICAL COMPLICATIONS OF CANCER
(19)
Neurofibromatosis and other Predisposition Syndromes
(19)
P04 Computational neuro-oncology
(19)
P04 LOW GRADE GLIOMA
(19)
PEDIATRIC NEURO-ONCOLOGY IN LOW/MIDDLE INCOME COUNTRIES
(19)
Randomized Brain Tumor Trials in Development
(19)
CNS Metastasis (MET)
(18)
EP12 Adult glioma
(18)
Final Category: Ongoing Clinical Trials
(18)
Final Category: Research Methods and Trial Design Considerations
(18)
Final category: Clinical Trials: Pediatrics
(18)
Final category: Drug delivery
(18)
Index
(18)
MENINGIOMA
(18)
P04 Tumor heterogeneity, plasticity and impact on therapeutic response
(18)
P13 Preclinical neuro-oncology
(18)
P13 Radiation technologies/Radiobiology/Radiotoxicity/Radiosensitizers
(18)
P14 Liquid biomarkers
(18)
P17 Radiation oncology
(18)
P22 QoL/Palliative care, end of life and care giving
(18)
Quality of life
(18)
Surgical/Intraoperative Therapy/Monitoring (STMO)
(18)
CIRCULATING BIOMARKERS IN CNS TUMORS (DNA, EXOSOMES, TUMOR CELLS, PLATELETS, OTHER)
(17)
EPIGENETICS
(17)
Final category: Craniopharyngioma
(17)
Final category: Early Phase Clinical Trials/Developmental Therapeutics
(17)
Invited Speakers
(17)
LOW GRADE GLIOMAS
(17)
Metabolic Fluxes and Signaling of Metabolic Pathways
(17)
NEURO-ONCOLOGY IN LOW AND MIDDLE INCOME COUNTRIES
(17)
NEUROCOGNITIVE OUTCOMES
(17)
P02 Other Tumor - Preclinical Aspects
(17)
P09 Imaging strategies
(17)
P13 Artificial intelligence/Machine learning/Computation
(17)
P19 Meningioma
(17)
SURGICAL/INTRAOPERATIVE THERAPY/MONITORING (STMO)
(17)
ANGIOGENESIS
(16)
Breaking News Editorials
(16)
Clinical Therapy Trials—Drug
(16)
EARLY PHASE/DRUG DISCOVERY
(16)
Final Category: Data Sciences/AI Advances
(16)
Final Category: Translational Therapeutics/Clinical Trials - TRLS
(16)
Final category: DNA repair/modulation
(16)
Final category: Preclinical Models, Drug Discovery
(16)
Highlights
(16)
Immunology/Immunotherapy
(16)
Medical Therapy (Chemotherapy, Targeted Therapy/Immunotherapy)
(16)
Meeting Report
(16)
Meningiomas
(16)
NEURO-COGNITIVE AND FUNCTIONAL OUTCOMES
(16)
Neurofibromatosis
(16)
OTHER EMBRYONAL TUMORS
(16)
P13 Brain and leptomeningeal metastases
(16)
P18 Quality of life
(16)
Pathology/Classification
(16)
Announcement
(15)
CELL BIOLOGY/METABOLISM/STEM CELLS (CBMS)
(15)
FINAL CATEGORY: BASIC SCIENCE OF LEPTOMENINGEAL DISEASE
(15)
FINAL CATEGORY: NEURO ONCOLOGY DIAGNOSTICS
(15)
Final category: Genomics, Epigenomics, Metabolomics
(15)
Final category: Local Therapies
(15)
P01 Tumor heterogeneity and plasticity
(15)
P07 Advanced techniques in Neuro-Oncology
(15)
P09 Low grade gliomas
(15)
P12 Brain tumor microenvironment
(15)
P12 Tumor microenvironment
(15)
P13 OMICS IN NEURO-ONCOLOGY
(15)
TUMOR METABOLISM
(15)
CELL SIGNALING
(14)
Epidemiology and Cancer Control
(14)
FINAL CATEGORY: SPINAL CORD TUMOR
(14)
Final Category: Other (Not Fitting in any Other Category) - OTHR
(14)
Final category: Biostatistics
(14)
Final category: DNA Repair/Modulation
(14)
Final category: Pathology, Classification
(14)
Metabolomics
(14)
Molecular Genetics
(14)
NEUROFIBROMATOSIS ASSOCIATED TUMORS (INCLUDING PLEXIFORMS)
(14)
Omics
(14)
P03 PATIENT-REPORTED OUTCOMES
(14)
P04 Pediatric brain tumors
(14)
P06 Neurocognition and connectome
(14)
P08 QoL/QoD
(14)
P26 Preclinical neuro-oncology (not covered by other topics)
(14)
Reply to Letter
(14)
SURGICAL THERAPIES
(14)
Biostatistics
(13)
Errata
(13)
Experimental Therapeutics (ET)
(13)
Final Category: Ependymoma - EPEN
(13)
Final Category: Genomics/Epigenomics/Metabolomics - METB
(13)
Final Category: Glioma
(13)
Final Category: Omics of Response to Therapy
(13)
Final category: Angiogenesis and invasion
(13)
Final category: Biological Correlates, Biomarkers
(13)
Final category: Neuroimaging
(13)
Guidelines
(13)
IMMUNOBIOLOGY/INFLAMMATION (CLINICAL AND/OR LABORATORY RESEARCH)
(13)
Invited Review
(13)
NEUROTOXICITY OF CANCER TREATMENT (EFFECTS ON CNS, PNS; PRECLINICAL AND CLINICAL/HUMAN STUDIES)
(13)
New developments in surgery
(13)
ORAL
(13)
Original Article
(13)
P01 Cell biology and signaling
(13)
P11 Pediatric brain tumours
(13)
P16 Leptomeningeal disease
(13)
P21 Miscellaneous
(13)
RARE CASE SERIES (CS)
(13)
BASIC BIOLOGY
(12)
Cell Biology/Metabolism/Stem Cells (CBMS)
(12)
Clinical Others
(12)
Drug Resistance
(12)
EXPERIMENTAL THERAPEUTICS (ET)
(12)
Final Category: Basic Science Brain Metastases
(12)
Final Category: Health Outcomes (QOL, DEI, Survivorship, Nursing, Social Work)- OUTC
(12)
Final Category: Omics of Tumor Evolution and Heterogeneity
(12)
Final category: Radiation Oncology
(12)
METABALOMICS
(12)
ORAL ABSTRACT PRESENTATIONS
(12)
P06 New targets
(12)
P07 Advanced Neurosurgical Techniques
(12)
P09 Symptoms and symptom management
(12)
P11 Meningiomas
(12)
P16 Pediatric brain tumors
(12)
late breaking abstracts
(12)
ATYPICAL TERTOID RHABDOID TUMOR (ATRT)
(11)
BRAINSTEM TUMORS
(11)
CNS METASTASIS (MET)
(11)
Cell Cycle Regulation
(11)
Final Category: Basic Science Leptomeningeal Disease
(11)
Medical Neuro-Oncology
(11)
Meta-analysis
(11)
Molecular Pathology/Classification
(11)
Neurotoxicity and neuroprotection
(11)
Neurotoxicity of Cancer Treatment
(11)
Nursing/Patient Care
(11)
P06 Immunology and immunotherapy: experimental
(11)
P08 QoL/Palliative care, end of life and care giving
(11)
P11 Connectome, functional neuro-oncology and cognition in brain tumors
(11)
PEDIATRIC CLINICAL TRIALS/THERAPEUTIC STUDIES (PEDT)
(11)
Review Article
(11)
Viral/Gene Therapy and other Novel Therapies
(11)
Adult Clinical Trials/Therapeutic Studies
(10)
Adult Clinical Trials/Therapeutic Studies (ACT)
(10)
Advances-in-Brief
(10)
Basic Biology
(10)
Cell Biology (CB)
(10)
Clinical Trials
(10)
FINAL CATEGORY: CLINICAL RESEARCH METHODS
(10)
FINAL CATEGORY: SKULL BASED/PITUITARY/SUPRASELLAR TUMORS
(10)
FINAL CATEGORY: SURVIVORSHIP/SUPPORTIVE CARE
(10)
Final Category: Computational and Statistical Approaches for Omics
(10)
Final Category: Imaging - IMG
(10)
Final Category: Novel Targets in CNS Metastases (Non-Immunologic)
(10)
Genetics/Epigenetics (GEN)
(10)
Immunotherapy and other novel targets
(10)
Low-grade gliomas
(10)
Malignant gliomas - clinical studies
(10)
New developments in neurosurgery
(10)
OTHER BRAIN TUMORS (BT)
(10)
OTHER CATEGORY
(10)
PALLIATIVE CARE, SYMPTOM MANAGEMENT
(10)
Primary central nervous system lymphoma (PCNSL)
(10)
Quality of life and supportive care
(10)
RADIATION THERAPY (RT)
(10)
Rapid Report
(10)
Supportive and palliative care
(10)
Consensus Review
(9)
Epigenome, Transcriptome, Metabolome and Modeling
(9)
FINAL CATEGORY: NEUROCOGNITIVE OUTCOMES, TOXICITY, AND QOL
(9)
FINAL CATEGORY: SUPPORTIVE CARE/HEALTH OUTCOMES
(9)
Final category: Multimodality Approaches
(9)
INTRAOPERATIVE TUMOR VISUALIZATION TECHNOLOGIES
(9)
Immunology (IM)
(9)
In vitro / in vivo models
(9)
Invited Point/Counterpoint
(9)
Metadata Analysis/Review
(9)
Neuro-Cognitive Function/QoL/Patient Care/Palliative Care (NQPC)
(9)
OS04 Selected abstracts: Clinical primary brain tumors
(9)
OS05 Selected abstracts: Basic and translational primary brain tumors
(9)
OS06 Highlights from clinical abstracts
(9)
OS07 Glioblastoma clinical
(9)
OS07 Highlights from clinical abstracts
(9)
OS07 Highlights from preclinical abstracts
(9)
OS08 Meningiomas, schwannomas and lymphomas
(9)
OS09 Immunology
(9)
P04 Immunology and immunotherapy
(9)
P12 Symptom management
(9)
P14 Neurotoxicity and neuroprotection
(9)
PRECLINICAL MODELS
(9)
Radiation Therapy (RT)
(9)
Retrospective Clinical Study
(9)
Reviewer Lists
(9)
SYMPTOM MANAGEMENT
(9)
Supportive Palliative Care
(9)
Surgical Therapy (ST)
(9)
Surgical/Intraoperative Therapy/Monitoring
(9)
TUMOR BIOLOGY/MODELS (TB)
(9)
Tumor Biology/Models (TB)
(9)
Announcements
(8)
Atypical Teratoid Rhabdoid Tumors
(8)
CEREBELLAR MUTISM SYNDROME
(8)
Clinical Research
(8)
Corrigenda and Errata
(8)
FINAL CATEGORY: ADULT GLIOMAS
(8)
Final Category: Spinal Tumors
(8)
Final Category: Supportive Care, Palliative Care and QOL
(8)
Final category: End of Life and Palliative Care
(8)
Final category: Immunotherapy
(8)
GENETICS/EPIGENETICS (GEN)
(8)
Malignant glioma - experimental studies
(8)
OS08 Highlights from preclinical abstracts
(8)
OS1 Cell Biology
(8)
OS2 Immunology
(8)
OS3 Models
(8)
OS4 Biomarker
(8)
OS5 Glioma: Clinical
(8)
OS6 Pediatric Brain Tumors
(8)
OS8 MENINGEOMA
(8)
OS9 OMICS IN NEURO-ONCOLOGY
(8)
P05 EARLY CLINICAL TRIALS
(8)
P05 Multilayer diagnostics
(8)
P09 MENINGEOMA
(8)
P16 Brain tumor microenvironment
(8)
P19 Cancer-Neuroscience
(8)
PL02 Award Winning Abstracts
(8)
Pediatric brain tumours
(8)
Rapid Reports
(8)
Article
(7)
BTC1 EANO-SNO Brain Tumor Club
(7)
CNS metastases and meningiomas
(7)
FINAL CATEGORY: CANCER EPIDEMIOLOGY/REGISTRY
(7)
FINAL CATEGORY: CNS METASTASES
(7)
FINAL CATEGORY: PRECLINICAL APPROACHES TO CNS METASTASES
(7)
Final Category: Germ Cell Tumors/Rare Tumors - RARE
(7)
Final Category: Radiation Oncology - XRT
(7)
Final Category: Spinal Cord Metastases
(7)
Final category: Neurosurgery, Drug Delivery
(7)
Final category: Tumor Biology, Stem Cells, Models
(7)
Immunology and immunotherapy
(7)
KEYWORD INDEX
(7)
Letter from the Editor
(7)
Models
(7)
Neuro-Cognitive Function/QOL/Patient Care/Palliative Care (NQPC)
(7)
OS01 Glioblastoma
(7)
OS02 Pediatric tumors
(7)
OS03 Brain metastasis
(7)
OS04 Neurosurgery and neuroimaging
(7)
OS05 Highlights from clinical abstracts
(7)
OS05 Quality of life, palliative care and neurotoxicity
(7)
OS06 Highlights from preclinical abstracts
(7)
OS06 Molecular and cell biology
(7)
OS09 Highlights from abstracts
(7)
OS1 Basic science and Pathology
(7)
OS1 LIQUID BIOMARKER
(7)
OS7 Non-Glioma
(7)
OS7 QOL
(7)
P02 Epidemiology
(7)
P03 Nursing Perspective
(7)
P05 Neurotoxicity and neuroprotection
(7)
P09 Symptom management
(7)
P10 Pediatric brain tumours
(7)
P21 Epidemiology/ Biobanks/ National registries
(7)
P23 Symptoms and symptom management
(7)
PCNSL
(7)
RANDOMIZED TRIALS IN DEVELOPMENT
(7)
Rare Case Series (CS)
(7)
Rare Cases (RC)
(7)
SIGNALING PATHWAYS/DRUG RESISTANCE (SPDR)
(7)
Solicited Review
(7)
CONNECTOME
(6)
Consensus Reviews
(6)
Correction
(6)
END LIFE AND PALLIATIVE CARE
(6)
EP09 Radiation
(6)
EP15 Palliative and supportive care/QoL
(6)
FINAL CATEGORY: AI AND INNOVATIVE TECHNOLOGY IN NEURO ONCOLOGY
(6)
FINAL CATEGORY: RARE TUMORS
(6)
Final Category: Next Generation Methods and Approaches
(6)
Final category: Diversity, Equity, and Inclusion
(6)
Final category: Neuroimaging: Pediatrics
(6)
IMMUNOLOGIC THERAPY (IMT)
(6)
Late Breaking Abstracts
(6)
MENINGIOMA (MNG)
(6)
MicroRNA
(6)
Molecular Tumor
(6)
OS06 Selected abstracts: Basic and clinical brain secondary tumors
(6)
OS10 HIGHLIGHT ABSTRACTS CLINICAL
(6)
OS10 Symptom management
(6)
OS12 HIGHLIGHT ABSTRACTS PRECLINICAL
(6)
OS2 Non-surgical Treatment
(6)
OS3 Molecular Genetics and Epigenetics
(6)
OS3 VALUE OF PATIENT-REPORTED OUTCOMES
(6)
OS4 Supportive Care
(6)
OS5 Pediatric Brain Tumors
(6)
P06 Pediatric brain tumors
(6)
P08 Liquid biomarkers
(6)
P08 QOL / QOD
(6)
P10 NEUROIMMUNOLOGY
(6)
P11 QoL/QoD
(6)
P15 Primary central nervous system lymphoma (PCNSL)
(6)
PL3 HOT TOPICS / LATE BREAKING ABSTRACTS
(6)
Pediatric Clinical Trials/Therapeutic Studies (PEDT)
(6)
RADIOBIOLOGY
(6)
RESISTANCE/RECURRENCE MECHANISMS
(6)
Retraction
(6)
Reviewer List
(6)
Spinal cord tumours
(6)
BASIC OTHERS (BOT)
(5)
BRAIN MAPPING
(5)
Disclosure Information
(5)
EP13 Meningioma
(5)
EP14 Rare CNS tumors
(5)
EP17 Clinical neuro-oncology
(5)
End of Life and Palliative Care
(5)
FLUORESCENCE-GUIDED SURGERY
(5)
Final Category: Immuno-Oncology Approaches
(5)
Final Category: Multi-omics
(5)
Final Category: Neurosurgery/Focused Ultrasound/Drug Delivery - SURG
(5)
Final Category: Omics in Molecular Pathology and Tumor Classification
(5)
Final category: Randomized Trials in Development
(5)
Final category: Surgical Therapies: Pediatrics
(5)
Genetics/Epigenetics
(5)
Invited lectureS (IL)
(5)
Letter to the Editors
(5)
Life Works (LW)
(5)
Neuropathology
(5)
OS11 Gliomas
(5)
OS6 General Clinical Neurooncology
(5)
OS6 METABOLIC PATHWAYS
(5)
P07 Immunology and immunotherapy: clinical
(5)
P13 Artifical intelligence/Machine learning/Computation
(5)
P17 Primary central nervous system lymphoma (PCNSL)
(5)
P19 Supportive and palliative care
(5)
P25 Epidemiology/ Biobanks/ National registries
(5)
PEDIATRIC TUMORS - CLINICAL TRIALS (NON-IMMUNOLOGICAL) (PHASES O, I, II, III, IV)
(5)
PHARMACOKINETICS
(5)
Retrospective Clinical Studies
(5)
SOCIAL WORK
(5)
SPINE ONCOLOGY (CLINICAL AND/OR LABORATORY RESEARCH)
(5)
SUPPORTIVE AND PALLIATIVE CARE
(5)
Special Focus: Pediatric Neuro-Oncology
(5)
Symposium Genetic Classification and Treatment of Malignant Gliomas and Oligodendrogliomas
(5)
Angiogenesis/Invasion (ANGI)
(4)
Basic and Translational
(4)
Brainstem Tumor
(4)
COVID-19 and Pediatric Neuro-Oncology
(4)
Call for Abstracts
(4)
Cell Biology/Metabolism/Stem Cells
(4)
Computational Omics (CO)
(4)
DEATH SIGNALING, APOPTOSIS AND AUTOPHAGY
(4)
FINAL CATEGORY: CLINICAL TRIALS - LOCAL THERAPIES
(4)
FINAL CATEGORY: CLINICAL TRIALS – SYSTEMIC OR INTRATHECAL (UPDATED)
(4)
FINAL CATEGORY: SUPPORTIVE AND PALLIATIVE CARE
(4)
Final Category: Cancer Neuroscience - CNSC
(4)
Final Category: Metastases
(4)
Final Category: Surgical Advances and Device Advances
(4)
Final Category: Translational Research
(4)
Final category: Cell cycle regulation
(4)
Final category: Supportive Care
(4)
IMMUNOLOGY (IM)
(4)
JS09 PET and MRI in patients with brain tumors
(4)
JS1 JOINT EAN-EANO SYMPOSIUM ON NEUROIMMUNOLOGY
(4)
KS01 The differential immune landscape in between primary and secondary brain tumors
(4)
Letter
(4)
List of Reviewers
(4)
Metadata Analysis
(4)
NEUROGENETIC TUMOR SUSCEPTIBILITY SYNDROMES - BIOLOGY AND TREATMENT (NEUROFIBROMATOSIS, TUBEROUS SCLEROSIS, VON HIPPEL LINDAU, COWDEN, OTHER)
(4)
News and Announcement
(4)
Novel Therapy (NT)
(4)
Nursing
(4)
OS03 Clinically relevant vulnerabilities of CNS metastasis
(4)
OS09 Quality of life
(4)
OS09 Survivorship and late effects
(4)
OS10 Cellular and molecular mapping of glioblastoma
(4)
OS10 Implications of neuron- and glial-like phenotypes in brain tumors
(4)
OS2 SPINAL TUMORS
(4)
OS4 EARLY CLINICAL TRIALS
(4)
OS5 DIPG
(4)
Other Brain Tumors (BT)
(4)
P04 Metabolism
(4)
P05 In vitro / in vivo models
(4)
P07 Sex-related influence on brain tumors
(4)
P09 Imaging strategies to improve neurosurgical outcome
(4)
P13 Brain and leptomeningeal metastases: experimental
(4)
P16 Public cancer policies and patient involvement
(4)
P16 Supportive and palliative care
(4)
P18 New developments in surgery
(4)
P22 Patient and public involvement
(4)
P24 Patient and public involvement
(4)
PL01 Artificial intelligence in Neuro-Oncology (and beyond)
(4)
PL03 Award Winning Abstracts
(4)
POINT/COUNTERPOINT
(4)
SIGNALING
(4)
Society News and Announcements
(4)
Symposia Epidemiology of Brain Tumors
(4)
Symposium on Angiogenesis, Part 1
(4)
Symposium on Low-Grade Glioma
(4)
ANGIOGENESIS/INVASION (ANGI)
(3)
Angiogenesis/Invasion
(3)
Case Studies/Case Illustration
(3)
Clinical Therapy Trials
(3)
Clinical Therapy Trials—Drugs
(3)
Clinical Therapy Trials—Quality of Life
(3)
EH1 EANO Highlights
(3)
EP10 Pediatric brain tumors
(3)
EP11 Brain metastasis and leptomeningeal disease
(3)
Fast-Track Articles
(3)
Final Category: Patient Advocacy
(3)
Final category: Palliative Care
(3)
INTRAOPERATIVE TUMOR DIAGNOSIS
(3)
Introduction
(3)
JS01 EANO Youngsters-CSNO: Imaging and Response Assessment - Present and Future
(3)
JS01 Treatment of rare CNS tumors
(3)
JS02 EANO-ESTRO: DNA repair inhibitors in glioma
(3)
JS03 EANO Youngsters-SIOP: Uniting frontiers against pediatric and adult brain tumors
(3)
JS03 EANO-EANM: Nucelar Medicine meets Neuro-Oncology
(3)
JS03 Impact on brain function by tumors or their treatments
(3)
JS04 Diffuse midline gliomas and other pediatric tumours
(3)
JS04 EANO-EANS: Clinical trials in surgical neuro-oncology
(3)
JS04 EANO-ESTRO: Emerging treatment strategies for adult-diffuse gliomas
(3)
JS04 Management of CNS tumors in the molecular era
(3)
JS05 EANO-EANS: Tumor-associated epilepsy
(3)
JS05 EANO-SNO: Translational Advances for Meningiomas
(3)
JS05 Surgical treatment of brain tumors
(3)
JS06 EANO-EANM: Therapy of meningioma
(3)
JS07 EANO-EACR: Navigating preclinical approaches to identify windows of opportunity and develop clinical trials
(3)
JS07 EANO-SNO: New Immunotherapies for rare gliomas in children and AYA
(3)
JS08 EANO-ESNR: Progress in MR imaging for brain tumor diagnosis and monitoring
(3)
JS08 Strategies to develop patient avatars or other patient surrogates for precision oncology
(3)
JS09 EANO-EACR: Dark matter of brain tumors’s genomes - structural genomics, epigenetics & epitranscriptomics
(3)
JS09 Maximising the therapeutic benefits of radiotherapy for brain tumours
(3)
KS01 Antibody-drug conjugates and other advanced therapeutics in Neuro-Oncology
(3)
KS01 Boosting immune responses in the brain
(3)
KS01 Can Immunotherapy Solve Glioblastoma’s Challenges? Strategies to Overcome Tumor Complexity
(3)
KS02 IDH inhibitors: clinical and molecular insights
(3)
KS02 Intraoperative detection and characterization of brain tumors
(3)
KS02 Person-centred care and implementation
(3)
KS03 Assembling the brain tumor microenvironment
(3)
KS03 Breaking the walls: efforts to democratize access to clinical information
(3)
KS03 Meningioma
(3)
KS04 Exploiting immunoregulatory hubs in brain tumors from biology to clinical trials
(3)
KS04 Molecular insights into oligodendrogliomas
(3)
KS05 Cellular-based immunotherapies
(3)
KS05 Treatment-induced plasticities
(3)
LATE BREAKING
(3)
LATE-BREAKING ABSTRACT
(3)
LYMPHOMA/LEUKEMIA (CLINICAL AND/OR LABORATORY RESEARCH)
(3)
Meningioma (MNG)
(3)
Neuro-Cognitive Function/QoL/Patient Care/Palliative Care
(3)
OS01 Liquid biomarkers for diagnosis/disease tracking in CNS tumours
(3)
OS01 Survivorship and long-term effects
(3)
OS02 Imaging/clinical focused AI-Enhanced Neuro-Oncology
(3)
OS02 Quality of Life and Symptom Management: state of the science
(3)
OS02 Symptom science and management
(3)
OS03 Diagnostics meets Artificial Intelligence
(3)
OS03 Exploiting dormancy, senescence and their links with the immune system in brain tumors
(3)
OS03 Exploring new radiation therapy technologies
(3)
OS03 Next generation brain tumor models and their utility for therapeutic discovery
(3)
OS04 Navigating fertility/pregnancy in patients with primary brain tumours
(3)
OS05 Dissecting and targeting pro-tumoral states of the microenvironment
(3)
OS05 Radiation necrosis: definition, diagnosis, management, prevention and future research
(3)
OS05 e-Health in Neuro-Oncology
(3)
OS06 Quality of life
(3)
OS06 Radiomics in Neuro-Oncology
(3)
OS07 Disease progression with high dimensional techniques
(3)
OS07 Palliative care in Neuro-Oncology
(3)
OS08 Advances in diagnosis and treatment of skull base tumors
(3)
OS08 Multilayer diagnostics
(3)
OS08 Quality of life and symptoms
(3)
OS08 Supramarginal resection
(3)
OS09 New target therapies in gliomas: TERT, ATRX, H3-K27M and TIM-3
(3)
OS09 Understanding the biology of IDH mutant gliomas as the basis for future treatment directions
(3)
OS10 Abstract highlights
(3)
OS10 Symptomatic and asymptomatic brain metastasis: consensus and implications for therapy
(3)
OS11 Impact of variables from the host in neuro-oncology research
(3)
OS11 Strategies to optimise surgical procedures for improved outcome
(3)
OS12 Brain tumors in AYA population
(3)
OS12 Efforts to improve management of incidental brain tumors
(3)
OS12 Rationalizing combination partners of immunotherapies
(3)
OS13 The role of population-based registries and retrospective studies in neuro-oncology
(3)
OS13 Update on molecular classification and treatment strategies for aggressive meningiomas and pitNETs
(3)
P03 Cancer-Neuroscience
(3)
P03 Cognition in brain tumors
(3)
P03 Quality of life
(3)
P07 Multilayer intra- and postoperative diagnostics and novel imaging technologies
(3)
P10 Advanced brain tumor models
(3)
P19 New developments in radiotherapy
(3)
P21 Other tumor entities
(3)
PEDIATRIC LABORATORY RESEARCH
(3)
PL02 Late Breaking Abstracts
(3)
PL02 New Molecular Insights: Oral Presentations
(3)
POINT-COUNTERPOINT
(3)
Paraneoplastic neurological syndromes
(3)
Pediatric Oral Presentations
(3)
Reply
(3)
Reviewer Acknowledgment
(3)
Signaling Pathways/Drug Resistance (SPDR)
(3)
Special Focus: Glioma
(3)
Symposium Childhood Brian Tumors
(3)
Symposium on Angiogenesis, Part 2
(3)
Top Scoring Oral
(3)
ADULT CLINICAL TRIALS (IMMUNOLOGICAL)
(2)
Acknowledgment to Reviewers for Neuro-Oncology
(2)
Author Index, AINO Abstracts
(2)
Author Index, Brain Tumor Research and Therapy Abstracts
(2)
Basic Others (BOT)
(2)
Clinical Neuro-oncology
(2)
Clinical Therapy Trails-Drug
(2)
Clinical Therapy Trails-Other
(2)
Clinical Therapy Trials - Other
(2)
Clinical Therapy Trials-Drug
(2)
Clinical Therapy Trials-Radiation
(2)
Clinical Therapy Trials—Outcomes
(2)
DNA DAMAGE, DNA REPAIR
(2)
EP03 Imaging
(2)
EP04 Computational neuro-oncology
(2)
EP08 Immunotherapy
(2)
Editorial Commentary
(2)
Epidemology and Cancer Control
(2)
Final Category: Pituitary Tumors
(2)
Final category: End of life and palliative care
(2)
Final category: Innovations in Spinal Tumors
(2)
Final category: Supportive Care and Survivorship
(2)
Full SNO 2020 Abstracts PDF
(2)
Immunologic Therapy
(2)
Invited Article
(2)
JS01 CSNO-EANO Youngsters
(2)
JS06 Optimizing radiosurgery and other therapeutic options for brain metastases
(2)
JS07 EURACAN: Progress in the EU Rare cancers network
(2)
JS07 Innovative PET techniques
(2)
JS08 Tumor Microenvironment Heterogeneity
(2)
KS01 Recurrent glioblastoma
(2)
KS02 Therapies for IDH-mutant gliomas
(2)
KS04 Management of Meningiomas
(2)
Keyword Index
(2)
Late Breaking
(2)
META-ANALYSES
(2)
Malignant glioma – experimental studies
(2)
Medical Therapy (Chemotherapy and Immunotherapy)
(2)
ORIGINAL RESEARCH ARTICLE
(2)
OS01 Emerging themes and novel treatments
(2)
OS01 Update on Response Assessment in Neuro-Oncology (RANO): projects and milestones
(2)
OS02 Addressing recruitment and disparity in clinical trials
(2)
OS02 Impact of tumor plasticity on experimental therapies
(2)
OS11 The leptomeninges in health and disease
(2)
OS12 Tissue focused AI-Enhanced Neuro-Oncology
(2)
OS14 Extent of resection
(2)
OTHER
(2)
Other Brain Tumors
(2)
P01 LIQUID BIOMARKER
(2)
P02 Radiobiology
(2)
P05 DNA damage
(2)
P05 Radiation technologies
(2)
P06 DIPG
(2)
P07 METABOLIC PATHWAYS
(2)
P08 Combined immunotherapies
(2)
P20 New developments in drug delivery
(2)
PL01 Brain connectome: implications for brain tumors and their treatments
(2)
PL01 Exploiting the immune system to challenge brain tumors
(2)
PL1 LOW GRADE GLIOMA
(2)
PL2 IMMUNOTHERAPY
(2)
Pediatric Neuro-Oncology Editorial
(2)
Perspective
(2)
Prelims
(2)
RADIOBIOLOGY (CLINICAL AND/OR LABORATORY RESEARCH)
(2)
REHABILITATION
(2)
Reviews/Other
(2)
SIGNALLING
(2)
Special lecture
(2)
Surgical Neuro-Oncology
(2)
Symposia Childhood Brain Tumors
(2)
Systematic reviews
(2)
TRACTOGRAPHY/WHITE MATTER PATHWAYS
(2)
Technologies for Studying Brain Metabolism
(2)
Tumor Biology/Models
(2)
Young Investigator Award Presentations
(2)
Young Investigator Presentations
(2)
13th Meeting of the European Association of Neurooncology October 10-14, 2018 Stockholm, Sweden
(1)
ASCO/SNO Guidelines
(1)
Abstracts from the 18th International Symposium on Pediatric Neuro-Oncology (ISPNO 2018) June 30 – July 3, 2018 Hyatt Regency Hotel Denver, Colorado, USA
(1)
Abstracts from the 2023 SNO/ASCO CNS Cancer Conference
(1)
Abstracts from the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 16 – 19, 2017, San Francisco, California
(1)
Abstracts from the 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, Louisiana
(1)
Abstracts from the BNOS 2017 Meeting June 21-23, 2017 John McIntyre Conference Centre, Edinburgh
(1)
Abstracts from the BNOS 2018 Meeting July 4–6, 2018 University of Winchester, UK
(1)
Author Index, EANO Abstracts
(1)
Author Index, From Gene to Cure Abstracts
(1)
Author Index, ISPNO Abstracts
(1)
Basic Others
(1)
Basic and Translational Investigations Editorial
(1)
Basic and Translational Invetigations
(1)
Biochemistry and Biophysics
(1)
Biomarker Therapies Supplement Article
(1)
Book reviews and editorial
(1)
Clinical Therapy Trails-Quality of Life
(1)
Clinical Therapy Trials - Outcome
(1)
Clinical Therapy Trials-Quality of Life
(1)
Clinical Therapy Trials—Radiation
(1)
EP06 Neurocognition and connectome
(1)
EP18 Preclinical neuro-oncology
(1)
EXPRESSION OF CONCERN
(1)
Editor's Note
(1)
Editorial Scholars Program
(1)
Epidemiology and Cancer Conrol
(1)
Epidemiology of spinal tumors
(1)
FINAL CATEGORY: CANCER BIOLOGY
(1)
FULL BNOS 2019 ABSTRACTS PDF
(1)
FULL EANO 2019 ABSTRACTS PDF
(1)
FULL ISPNO 2022 ABSTRACTS PDF
(1)
FULL SNO 2021 ANNUAL MEETING ABSTRACT
(1)
Fast-Track Article
(1)
Final Category: Health Economics
(1)
Full BNOS 2017 Abstracts PDF
(1)
Full BNOS 2018 Abstracts PDF
(1)
Full BNOS 2021 Abstracts PDF
(1)
Full EANO 2018 Abstracts PDF
(1)
Full EANO 2021 Abstracts PDF
(1)
Full ISPNO 2018 Abstracts PDF
(1)
Full SNO 2017 Abstracts PDF
(1)
Full SNO 2018 Abstracts PDF
(1)
Full SNO 2019 Abstracts PDF
(1)
Full SNO 2021 Abstracts PDF
(1)
Guideline
(1)
Guideline Statement
(1)
INDEX
(1)
Immunologic Therapy (IMT)
(1)
Immunotherapy Supplement Article
(1)
Initial symptom-directed management
(1)
Initial tumor-directed management
(1)
Introduction to Invited Point/Counterpoint
(1)
JS03 Tumor predisposition syndromes
(1)
JS06 EURACAN and rare brain cancers
(1)
KS02 Targeting aberrant DNA damage response phenotypes in glioma
(1)
LATE BREAKING ABSTRACT
(1)
Late-Breaking
(1)
Meeting Update
(1)
Message from the Editor-in-Chief
(1)
Metadata Analysis/Systematic Review
(1)
Multi-journal Editorial
(1)
Multidisciplinary program development and resources
(1)
Neurologic Complications of Cancer Therapy
(1)
OS04 Adjuvant treatment in Low Grade Gliomas
(1)
OS07 Cognition in brain tumors revisited: new technologies to improve outcome
(1)
OS11 Cellular origins of childhood brain tumors
(1)
OS13 Genome editing strategies for modelling brain tumors in mice
(1)
Online Supplementary Material
(1)
Online only
(1)
P02 SPINAL TUMORS
(1)
P12 Spinal cord tumours
(1)
P15 DNA damage repair and genomic instability
(1)
P15 Paraneoplastic neurological syndromes
(1)
Pediatric Experimental Therapeutics
(1)
Presentation of spinal tumors
(1)
Rare Case Series
(1)
Reply to Letter to the Editor
(1)
Review-in-Brief
(1)
Reviewer Lists for Neuro-Oncology
(1)
Reviews, Case Series, Rapid Reports
(1)
SNOSSA Supplement Article
(1)
SPINAL ONCOLOGY (PRIMARY AND METASTATIC SPINAL CORD/COLUMN TUMORS)
(1)
Signaling Pathways/Drug Resistance
(1)
Subsequent symptom-directed management
(1)
Subsequent tumor-directed management
(1)
Survey Results
(1)
Survivorship in Neuro-Oncology: Improving Care by Advancing Science
(1)
Symposium Review
(1)
Systematic Review/Meta-analysis
(1)
Types of spinal tumors
(1)
WHO Classification Summary
(1)
Workshop Summary
(1)